Author

Christopher J. Oalmann

Vertero Therapeutics (United States)ORCID 0000-0002-1817-1022Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

A. Stewart Campbell· 1 shared Aenne HarbertsiD· 1 shared Bernd SchnabliD· 1 shared Debanjan DhariD· 1 shared Jennifer T. Lau· 1 shared Jonah SimoniD· 1 shared Marcos F. FondevilaiD· 1 shared Mary C. Conrad· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Stewart Campbell

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting Microbial Bile Salt Hydrolase Reprograms Bile Acid Metabolism and Ameliorates Metabolic Dysfunction-Associated Steatohepatitis in Mice

Wenchao Wei, Radka Graf, Yanhan Wang, Christopher J. Oalmann, Jennifer T. Lau, Xinyi Wang, Melanie Chien, Mary C. Conrad, Jonah Simon, Souradipta Ganguly, Tomoo Yamazaki, Aenne Harberts, Sainan Chen, Marcos F. Fondevila, Debanjan Dhar, , Bernd Schnabl

This study shows that the BSH inhibitor GR-7 reduces steatosis, inflammation, and fibrosis in a mouse model of MASH through bile acid metabolism reprogramming and immune modulation.

Molecular Metabolism · Aug 18, 2026Peer-reviewedPharmacology & Toxicology